Literature DB >> 3834836

Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis.

C W Yim, N M Flynn, F T Fitzgerald.   

Abstract

Five patients with laboratory evidence of latent or neurosyphilis were treated orally with doxycycline (200 mg) twice a day for 21 days. After the seventh dose, the mean level of doxycycline in serum was 5.8 micrograms/ml, with a mean drug level in cerebrospinal fluid of 1.3 micrograms/ml. The mean penetration into cerebrospinal fluid was 26%. These preliminary findings suggest that doxycycline, administered orally at a dose of 200 mg twice a day, reaches a sufficient concentration in cerebrospinal fluid to be worthy of further evaluation as an alternative regimen to penicillin therapy for latent or neurosyphilis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834836      PMCID: PMC180244          DOI: 10.1128/AAC.28.2.347

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  The penetration of doxycycline into CSF.

Authors:  H Andersson; K Alestig
Journal:  Scand J Infect Dis Suppl       Date:  1976

2.  Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

Authors:  M Barza; R B Brown; C Shanks; C Gamble; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

Review 3.  Biopharmacology of syphilotherapy.

Authors:  M F Rein
Journal:  J Am Vener Dis Assoc       Date:  1976-12

4.  Persistence of Treponema pallidum following penicillin G therapy. Report of two cases.

Authors:  E C Tramont
Journal:  JAMA       Date:  1976-11-08       Impact factor: 56.272

5.  Failure of penicillin G benzathine in the treatment of neurosyphilis.

Authors:  B M Greene; N R Miller; T E Bynum
Journal:  Arch Intern Med       Date:  1980-08

6.  Neurosyphilis and penicillin levels in cerebrospinal fluid.

Authors:  J A Mohr; W Griffiths; R Jackson; H Saadah; P Bird; J Riddle
Journal:  JAMA       Date:  1976-11-08       Impact factor: 56.272

7.  Therapeutic effect of oral doxycycline on syphilis.

Authors:  Y Onoda
Journal:  Br J Vener Dis       Date:  1979-04
  7 in total
  37 in total

1.  Failure of azithromycin in treatment of Brill-Zinsser disease.

Authors:  D Turcinov; I Kuzman; B Herendić
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 2.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Neurosyphilis: A Current Review.

Authors:  Judith A O'donnell; Christopher L Emery
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

Review 4.  Neurosyphilis with optic neuritis: an update.

Authors:  G T Smith; D Goldmeier; C Migdal
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

5.  Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.

Authors:  Damian N Meli; Roney S Coimbra; Dominik G Erhart; Gerard Loquet; Caroline L Bellac; Martin G Täuber; Ulf Neumann; Stephen L Leib
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Outcome of intravenous azithromycin therapy in patients with complicated scrub typhus compared with that of doxycycline therapy using propensity-matched analysis.

Authors:  Mi-Ok Jang; Hee-Chang Jang; Uh Jin Kim; Joon Hwan Ahn; Seung-Ji Kang; Sook-In Jung; Hee-Young Shin; Kyung-Hwa Park
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

7.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

8.  Doxycycline Used for Control of Transgene Expression has its Own Effects on Behaviors and Bcl-xL in the Rat Hippocampus.

Authors:  G T Shishkina; D A Lanshakov; A V Bannova; T S Kalinina; N P Agarina; N N Dygalo
Journal:  Cell Mol Neurobiol       Date:  2017-08-31       Impact factor: 5.046

Review 9.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.